GenSight Biologics' Series A Round

GenSight Biologics raised a round of funding on April 08, 2013.

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. To addre…

Articles about GenSight Biologics' Series A Round: